Helicobacter pylori 的血清流行率和发生的心肌梗塞 - 一个基于人口的瑞典嵌套病例控制研究
Martin O Sundqvist1, Per Svensson1, Stefan Söderberg2
1Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Södersjukhuset, Stockholm, Sweden.
International journal of cardiology
|December 17, 2024
概括
这项研究发现,在瑞典人群中,Helicobacter pylori (H. pylori) 感染或其CagA毒素与心肌梗塞 (MI) 风险之间没有显著的联系. 需要进一步的研究来澄清潜在的关联.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 杆菌 (H. pylori) 及其CagA蛋白与各种疾病有关,一些研究表明与心肌梗塞 (MI) 有关.
- 关于H. pylori/CagA和MI之间的关联存在相互矛盾的证据,可能是由于研究设计的局限性和未解决的混因素.
研究的目的:
- 调查H. pylori和CagA血清阳性与心脏病发作的发生率之间的联系,包括心脏病发作的表型.
- 检查H. pylori流行的时间趋势及其与心脏病发作之间的关系.
主要方法:
- 使用北瑞典健康和疾病研究生物库 (1986-2006) 进行的前性队列研究.
- 包括826例首次心脏病发作病例与对照组相匹配 1:2.
- 血液样本通过ELISA分析H. pylori和CagA血清流行率.
主要成果:
- H. pylori和CagA血清流行率在病例中分别为46.5%和32.1%,而对照组为43.7%和30.6%.
- 在研究期间,H. pylori的患病率呈现下降趋势.
- 多变量分析显示,H. pylori或CagA血清阳性和发生的MI之间没有显著的关联.
结论:
- 在这个基于瑞典人口的队列中,没有发现H. pylori或CagA血清阳性与心脏病发病率之间的显著关联.
- 这些发现表明,H. pylori和CagA可能不是该人群中心脏病发作的重要危险因素.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
326
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
326
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
88
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
88
01:30Peptic Ulcer Disease I: Introduction
133
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
133
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
542
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
542
01:23Gastritis III: Clinical Manifestations and Management
153
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
153
01:17Gastritis-II: Pathophysiology
242
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
242